You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Raw chart and full-history price indicators begin at the captured split on Dec 19, 2025; bars on opposite sides are not compared.
The closing range begins at the captured split on Dec 19, 2025.
Dr. Lal Path Labs Ltd reported Q2 FY27 revenue of Rs. 874 crore, up 19.6%, and PAT of Rs. 194 crore, up 27.5%, with a 22.2% margin. Management expects FY27 revenue growth in the high teens and full-year EBITDA margin slightly above 27.2%.
Illustrative technical + ownership context — a signal mix, not investment advice.
Raw-price comparisons begin at the captured split on Dec 19, 2025; windows that need an earlier baseline remain unavailable.
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| XNSE:LALPATHLAB | +1.2% | +5.7% | +22.3% | +4.5% | +34.4% |
Share classes and depositary receipts can have different prices and dividends.
| Ex-dividend date | Amount per share |
|---|---|
| 2026-11-11 | 5.00 INR |
| 2026-07-30 | 5.00 INR |
| 2026-06-25 | 4.00 INR |
| 2026-02-05 | 3.50 INR |
| 2025-11-07 | 3.50 INR |
| 2025-08-06 | 3.00 INR |
| 2025-06-06 | 3.00 INR |
| 2025-02-05 | 3.00 INR |
| 2024-11-05 | 3.00 INR |
| 2024-08-20 | 3.00 INR |
| 2024-06-10 | 3.00 INR |
| 2024-02-13 | 6.00 INR |
| 2023-08-11 | 6.00 INR |
| 2022-08-05 | 3.00 INR |
| 2022-06-22 | 3.00 INR |
| 2021-08-18 | 3.00 INR |
| 2021-07-20 | 4.00 INR |
| 2021-02-09 | 3.00 INR |
| 2020-11-18 | 3.00 INR |
| 2020-03-05 | 3.00 INR |
No upcoming investor events are listed for this company yet.
